{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:29:52Z","timestamp":1793039392035,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":106,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82571418"],"award-info":[{"award-number":["82571418"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32530027"],"award-info":[{"award-number":["32530027"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2024C03098"],"award-info":[{"award-number":["2024C03098"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovative Institute of Basic Medical Science of Zhejiang University","id":[{"id":"https:\/\/ror.org\/055qbch41","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-026-01432-6","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T12:15:26Z","timestamp":1781180126000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Associations of DTI-ALPS index and choroid plexus volume with clinical severity across the Parkinson\u2019s disease spectrum"],"prefix":"10.1038","volume":"12","author":[{"given":"Yujue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"1432_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13024-023-00630-7","volume":"18","author":"J Lee","year":"2023","unstructured":"Lee, J. et al. Targeted degradation of \u03b1-synuclein aggregates in Parkinson\u2019s disease using the AUTOTAC technology. Mol. Neurodegener 18, 41 (2023).","journal-title":"Mol. Neurodegener"},{"key":"1432_CR2","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41593-024-01866-2","volume":"28","author":"X Yuan","year":"2025","unstructured":"Yuan, X. et al. Propagation of pathologic \u03b1-synuclein from kidney to brain may contribute to Parkinson\u2019s disease. Nat. Neurosci. 28, 577\u2013588 (2025).","journal-title":"Nat. Neurosci."},{"key":"1432_CR3","doi-asserted-by":"publisher","first-page":"e2405364","DOI":"10.1002\/advs.202405364","volume":"11","author":"W Zhang","year":"2024","unstructured":"Zhang, W. et al. Nanotherapeutic approaches of interleukin-3 to clear the \u03b1-synuclein pathology in mouse models of Parkinson\u2019s disease. Adv. Sci. 11, e2405364 (2024).","journal-title":"Adv. Sci."},{"key":"1432_CR4","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/brain\/awab428","volume":"145","author":"LP Carlstrom","year":"2022","unstructured":"Carlstrom, L. P. et al. A clinical primer for the glymphatic system. Brain 145, 843\u2013857 (2022).","journal-title":"Brain"},{"key":"1432_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40035-019-0147-y","volume":"8","author":"W Zou","year":"2019","unstructured":"Zou, W. et al. Blocking meningeal lymphatic drainage aggravates Parkinson\u2019s disease-like pathology in mice overexpressing mutated \u03b1-synuclein. Transl. Neurodegener 8, 7 (2019).","journal-title":"Transl. Neurodegener"},{"key":"1432_CR6","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1093\/brain\/awaa179","volume":"143","author":"IF Harrison","year":"2020","unstructured":"Harrison, I. F. et al. Impaired glymphatic function and clearance of tau in an Alzheimer\u2019s disease model. Brain 143, 2576\u20132593 (2020).","journal-title":"Brain"},{"key":"1432_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02770-5","volume":"20","author":"Z Liu","year":"2023","unstructured":"Liu, Z. et al. The cervical lymph node contributes to peripheral inflammation related to Parkinson\u2019s disease. J. Neuroinflamm 20, 93 (2023).","journal-title":"J. Neuroinflamm"},{"key":"1432_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s11604-017-0617-z","volume":"35","author":"T Taoka","year":"2017","unstructured":"Taoka, T. et al. Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer\u2019s disease cases. Jpn J. Radio. 35, 172\u2013178 (2017).","journal-title":"Jpn J. Radio."},{"key":"1432_CR9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41531-025-01018-8","volume":"11","author":"J Nepozitek","year":"2025","unstructured":"Nepozitek, J. et al. Glymphatic dysfunction evidenced by DTI-ALPS is related to obstructive sleep apnea intensity in newly diagnosed Parkinson\u2019s disease. NPJ Parkinsons Dis. 11, 160 (2025).","journal-title":"NPJ Parkinsons Dis."},{"key":"1432_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41531-025-00921-4","volume":"11","author":"S Marecek","year":"2025","unstructured":"Marecek, S. et al. Exploring glymphatic system alterations in iRBD and Parkinson\u2019s disease using automated DTI-ALPS analysis. NPJ Parkinsons Dis. 11, 76 (2025).","journal-title":"NPJ Parkinsons Dis."},{"key":"1432_CR11","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1002\/mds.30325","volume":"40","author":"A Zarkali","year":"2025","unstructured":"Zarkali, A. et al. Impaired glymphatic clearance, measured using diffusion tensor image analysis along the perivascular space (DTI-ALPS), is linked to poor cognitive outcomes in Parkinson\u2019s disease. Mov. Disord. 40, 2367\u20132380 (2025).","journal-title":"Mov. Disord."},{"key":"1432_CR12","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/mds.29908","volume":"39","author":"KH Wood","year":"2024","unstructured":"Wood, K. H. et al. Diffusion tensor imaging-along the perivascular-space index is associated with disease progression in Parkinson\u2019s disease. Mov. Disord. 39, 1504\u20131513 (2024).","journal-title":"Mov. Disord."},{"key":"1432_CR13","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1038\/s41380-022-01623-6","volume":"27","author":"BKY Bitanihirwe","year":"2022","unstructured":"Bitanihirwe, B. K. Y., Lizano, P. & Woo, T. W. Deconstructing the functional neuroanatomy of the choroid plexus: an ontogenetic perspective for studying neurodevelopmental and neuropsychiatric disorders. Mol. Psychiatry 27, 3573\u20133582 (2022).","journal-title":"Mol. Psychiatry"},{"key":"1432_CR14","doi-asserted-by":"publisher","first-page":"105987","DOI":"10.1016\/j.parkreldis.2023.105987","volume":"120","author":"P He","year":"2024","unstructured":"He, P. et al. The association of CSF biomarkers and cognitive decline with choroid plexus volume in early Parkinson\u2019s disease. Parkinsonism Relat. Disord. 120, 105987 (2024).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1432_CR15","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1177\/0271678X221082786","volume":"42","author":"J Christensen","year":"2022","unstructured":"Christensen, J., Li, C. & Mychasiuk, R. Choroid plexus function in neurological homeostasis and disorders: The awakening of the circadian clocks and orexins. J. Cereb. Blood Flow. Metab. 42, 1163\u20131175 (2022).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"1432_CR16","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1136\/jnnp-2023-331170","volume":"94","author":"SH Jeong","year":"2023","unstructured":"Jeong, S. H. et al. Association of choroid plexus volume with motor symptoms and dopaminergic degeneration in Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 94, 1047\u20131055 (2023).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1432_CR17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neurobiolaging.2020.01.005","volume":"89","author":"E Tadayon","year":"2020","unstructured":"Tadayon, E., Pascual-Leone, A., Press, D. & Santarnecchi, E. Choroid plexus volume is associated with levels of CSF proteins: relevance for Alzheimer\u2019s and Parkinson\u2019s disease. Neurobiol Aging 89, 108\u2013117 (2020).","journal-title":"Neurobiol Aging"},{"key":"1432_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/0271678X221129101","volume":"43","author":"JJ Eisma","year":"2023","unstructured":"Eisma, J. J. et al. Choroid plexus perfusion and bulk cerebrospinal fluid flow across the adult lifespan. J. Cereb. Blood Flow. Metab. 43, 269\u2013280 (2023).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"1432_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/0031-9384(84)90269-5","volume":"32","author":"RL Doty","year":"1984","unstructured":"Doty, R. L., Shaman, P. & Dann, M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol. Behav. 32, 489\u2013502 (1984).","journal-title":"Physiol. Behav."},{"key":"1432_CR20","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine, Z. S. et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53, 695\u2013699 (2005).","journal-title":"J. Am. Geriatr. Soc."},{"key":"1432_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-04356-8","volume":"12","author":"LL Raket","year":"2022","unstructured":"Raket, L. L. et al. Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson\u2019s disease. Sci. Rep. 12, 526 (2022).","journal-title":"Sci. Rep."},{"key":"1432_CR22","doi-asserted-by":"publisher","first-page":"121705","DOI":"10.1016\/j.neuroimage.2026.121705","volume":"326","author":"X Ruan","year":"2026","unstructured":"Ruan, X. et al. ALPS index and choroid plexus volume as indirect MRI biomarkers of glymphatic function for predicting cognitive decline in Parkinson\u2019s disease. Neuroimage 326, 121705 (2026).","journal-title":"Neuroimage"},{"key":"1432_CR23","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/JPD-191683","volume":"9","author":"S Cerri","year":"2019","unstructured":"Cerri, S., Mus, L. & Blandini, F. Parkinson\u2019s disease in women and men: What\u2019s the difference? J. Parkinsons Dis. 9, 501\u2013515 (2019).","journal-title":"J. Parkinsons Dis."},{"key":"1432_CR24","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim, T., Jette, N., Frolkis, A. & Steeves, T. D. The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis. Mov. Disord. 29, 1583\u20131590 (2014).","journal-title":"Mov. Disord."},{"key":"1432_CR25","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.sleep.2014.10.020","volume":"16","author":"J Zhou","year":"2015","unstructured":"Zhou, J. et al. Gender differences in REM sleep behavior disorder: a clinical and polysomnographic study in China. Sleep. Med 16, 414\u2013418 (2015).","journal-title":"Sleep. Med"},{"key":"1432_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neuint.2017.09.003","volume":"117","author":"SM Jaber","year":"2018","unstructured":"Jaber, S. M. et al. Sex differences in the mitochondrial bioenergetics of astrocytes but not microglia at a physiologically relevant brain oxygen tension. Neurochem Int. 117, 82\u201390 (2018).","journal-title":"Neurochem Int."},{"key":"1432_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13293-025-00692-w","volume":"16","author":"SL Schaffner","year":"2025","unstructured":"Schaffner, S. L., Tosefsky, K. N., Inskter, A. M., Appel-Cresswell, S. & Schulze-Hentrich, J. M. Sex and gender differences in the molecular etiology of Parkinson\u2019s disease: considerations for study design and data analysis. Biol. Sex. Differ. 16, 7 (2025).","journal-title":"Biol. Sex. Differ."},{"key":"1432_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","volume":"16","author":"DJ Irwin","year":"2017","unstructured":"Irwin, D. J. et al. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol 16, 55\u201365 (2017).","journal-title":"Lancet Neurol"},{"key":"1432_CR29","doi-asserted-by":"publisher","first-page":"107001","DOI":"10.1016\/j.nbd.2025.107001","volume":"213","author":"Z Zhu","year":"2025","unstructured":"Zhu, Z. et al. Glymphatic dysfunction is related to motor disability fully mediated by gray matter degeneration in early-stage Parkinson\u2019s disease. Neurobiol. Dis. 213, 107001 (2025).","journal-title":"Neurobiol. Dis."},{"key":"1432_CR30","doi-asserted-by":"publisher","unstructured":"Roura, I. et al. Circadian alterations in isolated REM sleep behavior disorder: associations with clinical, glymphatic and, dopaminergic imaging markers. Sleep, https:\/\/doi.org\/10.1093\/sleep\/zsaf418 (2026).","DOI":"10.1093\/sleep\/zsaf418"},{"key":"1432_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41531-025-00942-z","volume":"11","author":"I Roura","year":"2025","unstructured":"Roura, I. et al. Clinical and brain volumetric correlates of decreased DTI-ALPS, suggestive of local glymphatic dysfunction, in iRBD. NPJ Parkinsons Dis. 11, 87 (2025).","journal-title":"NPJ Parkinsons Dis."},{"key":"1432_CR32","doi-asserted-by":"publisher","first-page":"e214042","DOI":"10.1212\/WNL.0000000000214042","volume":"105","author":"V Ayral","year":"2025","unstructured":"Ayral, V. et al. Association of DTI-ALPS Glymphatic Index With Differential Phenoconversion in Isolated REM Sleep Behavior Disorder: A Multi-Cohort MRI Study. Neurology 105, e214042 (2025).","journal-title":"Neurology"},{"key":"1432_CR33","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00415-023-12004-6","volume":"271","author":"JC Meng","year":"2024","unstructured":"Meng, J. C. et al. Correlation of glymphatic system abnormalities with Parkinson\u2019s disease progression: a clinical study based on non-invasive fMRI. J. Neurol 271, 457\u2013471 (2024).","journal-title":"J. Neurol"},{"key":"1432_CR34","doi-asserted-by":"publisher","first-page":"e221848","DOI":"10.1148\/radiol.221848","volume":"307","author":"YJ Bae","year":"2023","unstructured":"Bae, Y. J. et al. Altered Brain Glymphatic Flow at Diffusion-Tensor MRI in Rapid Eye Movement Sleep Behavior Disorder. Radiology 307, e221848 (2023).","journal-title":"Radiology"},{"key":"1432_CR35","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41531-022-00316-9","volume":"8","author":"X Si","year":"2022","unstructured":"Si, X. et al. Neuroimaging evidence of glymphatic system dysfunction in possible REM sleep behavior disorder and Parkinson\u2019s disease. NPJ Parkinsons Dis. 8, 54 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"1432_CR36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41531-025-00962-9","volume":"11","author":"X Ma","year":"2025","unstructured":"Ma, X. et al. Parkinson\u2019s disease with possible REM sleep behavior disorder correlated with more severe glymphatic system dysfunction. NPJ Parkinsons Dis. 11, 82 (2025).","journal-title":"NPJ Parkinsons Dis."},{"key":"1432_CR37","doi-asserted-by":"publisher","first-page":"105767","DOI":"10.1016\/j.parkreldis.2023.105767","volume":"114","author":"YJ Bae","year":"2023","unstructured":"Bae, Y. J. et al. Glymphatic function assessment in Parkinson\u2019s disease using diffusion tensor image analysis along the perivascular space. Parkinsonism Relat. Disord. 114, 105767 (2023).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1432_CR38","doi-asserted-by":"publisher","first-page":"108014","DOI":"10.1016\/j.parkreldis.2025.108014","volume":"140","author":"MJ Firbank","year":"2025","unstructured":"Firbank, M. J. et al. Changes in DTI-ALPS index and its associations with neuronal damage in Lewy body disease. Parkinsonism Relat. Disord. 140, 108014 (2025).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1432_CR39","doi-asserted-by":"publisher","first-page":"268","DOI":"10.2463\/mrms.rev.2023-0175","volume":"23","author":"T Taoka","year":"2024","unstructured":"Taoka, T. et al. Diffusion Tensor Image Analysis ALong the Perivascular Space (DTI-ALPS): Revisiting the Meaning and Significance of the Method. Magn. Reson Med Sci. 23, 268\u2013290 (2024).","journal-title":"Magn. Reson Med Sci."},{"key":"1432_CR40","doi-asserted-by":"publisher","first-page":"eadv8269","DOI":"10.1126\/science.adv8269","volume":"389","author":"SA Keil","year":"2025","unstructured":"Keil, S. A., Jansson, D., Braun, M. & Iliff, J. J. Glymphatic dysfunction in Alzheimer\u2019s disease: a critical appraisal. Science 389, eadv8269 (2025).","journal-title":"Science"},{"key":"1432_CR41","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13024-025-00866-5","volume":"20","author":"M Passaretti","year":"2025","unstructured":"Passaretti, M. et al. Clinical progression and genetic pathways in body-first and brain-first Parkinson\u2019s disease. Mol. Neurodegener. 20, 74 (2025).","journal-title":"Mol. Neurodegener."},{"key":"1432_CR42","unstructured":"The Parkinson Progression Marker Initiative (PPMI). Prog Neurobiol 95, 629\u2013635 (2011)."},{"key":"1432_CR43","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/acn3.644","volume":"5","author":"K Marek","year":"2018","unstructured":"Marek, K. et al. The Parkinson\u2019s Progression Markers Initiative (PPMI) - establishing a PD biomarker cohort. Ann. Clin. Transl. Neurol 5, 1460\u20131477 (2018).","journal-title":"Ann. Clin. Transl. Neurol"},{"key":"1432_CR44","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz, C. G. et al. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 23, 2129\u20132170 (2008).","journal-title":"Mov. Disord."},{"key":"1432_CR45","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn, M. M. & Yahr, M. D. Parkinsonism: onset, progression and mortality. Neurology 17, 427\u2013442 (1967).","journal-title":"Neurology"},{"key":"1432_CR46","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1002\/mds.21740","volume":"22","author":"K Stiasny-Kolster","year":"2007","unstructured":"Stiasny-Kolster, K. et al. The REM sleep behavior disorder screening questionnaire\u2013a new diagnostic instrument. Mov. Disord. 22, 2386\u20132393 (2007).","journal-title":"Mov. Disord."},{"key":"1432_CR47","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1212\/WNL.0b013e3181c34b47","volume":"73","author":"S Hoops","year":"2009","unstructured":"Hoops, S. et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 73, 1738\u20131745 (2009).","journal-title":"Neurology"},{"key":"1432_CR48","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.2044-8260.1992.tb00997.x","volume":"31","author":"TM Marteau","year":"1992","unstructured":"Marteau, T. M. & Bekker, H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br. J. Clin. Psychol. 31, 301\u2013306 (1992).","journal-title":"Br. J. Clin. Psychol."},{"key":"1432_CR49","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12987-024-00554-4","volume":"21","author":"J Li","year":"2024","unstructured":"Li, J. et al. Associations between the choroid plexus and tau in Alzheimer\u2019s disease using an active learning segmentation pipeline. Fluids Barriers CNS 21, 56 (2024).","journal-title":"Fluids Barriers CNS"},{"key":"1432_CR50","doi-asserted-by":"publisher","first-page":"121392","DOI":"10.1016\/j.neuroimage.2025.121392","volume":"318","author":"J Li","year":"2025","unstructured":"Li, J. et al. Morphological changes of the choroid plexus in the lateral ventricle across the lifespan: 5551 subjects from fetus to elderly. Neuroimage 318, 121392 (2025).","journal-title":"Neuroimage"},{"key":"1432_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-025-03432-1","volume":"15","author":"H Xia","year":"2025","unstructured":"Xia, H. et al. Association of choroid plexus volume with white matter microstructure, glymphatic function, and peripheral systemic inflammation in Alzheimer\u2019s disease. Transl. Psychiatry 15, 238 (2025).","journal-title":"Transl. Psychiatry"},{"key":"1432_CR52","doi-asserted-by":"publisher","first-page":"11050","DOI":"10.1073\/pnas.200033797","volume":"97","author":"B Fischl","year":"2000","unstructured":"Fischl, B. & Dale, A. M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl. Acad. Sci. USA 97, 11050\u201311055 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01432-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01432-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01432-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:27:44Z","timestamp":1790288864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01432-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1432"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01432-6","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"234"}}